- Telehealth Visits
- Insurance plan information
Aaron Tward, MD, PhD
Neurotology- Telehealth Visits
- Insurance plan information
Otolaryngology/Head & Neck Surgery Mount Zion
Aaron Tward, MD, PhD
NeurotologyOtolaryngology/Head & Neck Surgery Mount Zion
- Telehealth Visits
- Insurance plan information
On this page
Education & training
Board certification
- Neurotology, American Board of Otolaryngology
- Otolaryngology - Head & Neck Surgery, American Board of Otolaryngology
Fellowship
- Otolaryngology, Massachusetts Eye and Ear Infirmary- Chief & Chair
Residency
- Otolaryngology, Harvard University Medical School
Internship
- General Surgery, Brigham and Womens Hospital GME
Degree
- MD, UCSF School of Medicine
My expertise
Specialties
Locations
Component Name: Provider Research Listing component built but no clinical trials or publications to display
Clinical Trials query: q=health_gateway_id_ss%3A%28%222283%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%222283%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.